Cancer antigens are certain types of proteins secreted into the bloodstream and can be measured in both cancers and non-cancerous conditions. Cancer antigens are the tumour markers produced by cancer cells and other cells of the body which provides information about cancer.
This report aims to provide a comprehensive presentation of the global market for Cancer Antigen, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Antigen. This report contains market size and forecasts of Cancer Antigen in global, including the following market information:
Global Cancer Antigen Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cancer Antigen market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Cancer Antigen 125 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cancer Antigen include Thermo Fisher Scientific, Roche, Tellgen, Labor Diagnostika Nord, Henso Medical (Hangzhou), Multisciences (Lianke) Biotech, Hangzhou AllTest Biotech, SHINJIN Medics and Xiamen Baysen Medica Tech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Antigen companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Antigen Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cancer Antigen Market Segment Percentages, by Type, 2022 (%)
Cancer Antigen 125
Cancer Antigen 15-3
Cancer Antigen 27-29
Cancer Antigen 19-9
Others
Global Cancer Antigen Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cancer Antigen Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Centres
Ambulatory Surgical Centres
Others
Global Cancer Antigen Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cancer Antigen Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Antigen revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Antigen revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Roche
Tellgen
Labor Diagnostika Nord
Henso Medical (Hangzhou)
Multisciences (Lianke) Biotech
Hangzhou AllTest Biotech
SHINJIN Medics
Xiamen Baysen Medica Tech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Antigen, market overview.
Chapter 2: Global Cancer Antigen market size in revenue.
Chapter 3: Detailed analysis of Cancer Antigen company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Antigen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Antigen Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Antigen Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Antigen Overall Market Size
2.1 Global Cancer Antigen Market Size: 2022 VS 2030
2.2 Global Cancer Antigen Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Antigen Players in Global Market
3.2 Top Global Cancer Antigen Companies Ranked by Revenue
3.3 Global Cancer Antigen Revenue by Companies
3.4 Top 3 and Top 5 Cancer Antigen Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Antigen Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Antigen Players in Global Market
3.6.1 List of Global Tier 1 Cancer Antigen Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Antigen Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Antigen Market Size Markets, 2022 & 2030
4.1.2 Cancer Antigen 125
4.1.3 Cancer Antigen 15-3
4.1.4 Cancer Antigen 27-29
4.1.5 Cancer Antigen 19-9
4.1.6 Others
4.2 By Type - Global Cancer Antigen Revenue & Forecasts
4.2.1 By Type - Global Cancer Antigen Revenue, 2018-2023
4.2.2 By Type - Global Cancer Antigen Revenue, 2024-2030
4.2.3 By Type - Global Cancer Antigen Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Antigen Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Diagnostic Centres
5.1.4 Ambulatory Surgical Centres
5.1.5 Others
5.2 By Application - Global Cancer Antigen Revenue & Forecasts
5.2.1 By Application - Global Cancer Antigen Revenue, 2018-2023
5.2.2 By Application - Global Cancer Antigen Revenue, 2024-2030
5.2.3 By Application - Global Cancer Antigen Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Cancer Antigen Market Size, 2022 & 2030
6.2 By Region - Global Cancer Antigen Revenue & Forecasts
6.2.1 By Region - Global Cancer Antigen Revenue, 2018-2023
6.2.2 By Region - Global Cancer Antigen Revenue, 2024-2030
6.2.3 By Region - Global Cancer Antigen Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Cancer Antigen Revenue, 2018-2030
6.3.2 US Cancer Antigen Market Size, 2018-2030
6.3.3 Canada Cancer Antigen Market Size, 2018-2030
6.3.4 Mexico Cancer Antigen Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Antigen Revenue, 2018-2030
6.4.2 Germany Cancer Antigen Market Size, 2018-2030
6.4.3 France Cancer Antigen Market Size, 2018-2030
6.4.4 U.K. Cancer Antigen Market Size, 2018-2030
6.4.5 Italy Cancer Antigen Market Size, 2018-2030
6.4.6 Russia Cancer Antigen Market Size, 2018-2030
6.4.7 Nordic Countries Cancer Antigen Market Size, 2018-2030
6.4.8 Benelux Cancer Antigen Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Antigen Revenue, 2018-2030
6.5.2 China Cancer Antigen Market Size, 2018-2030
6.5.3 Japan Cancer Antigen Market Size, 2018-2030
6.5.4 South Korea Cancer Antigen Market Size, 2018-2030
6.5.5 Southeast Asia Cancer Antigen Market Size, 2018-2030
6.5.6 India Cancer Antigen Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Cancer Antigen Revenue, 2018-2030
6.6.2 Brazil Cancer Antigen Market Size, 2018-2030
6.6.3 Argentina Cancer Antigen Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Antigen Revenue, 2018-2030
6.7.2 Turkey Cancer Antigen Market Size, 2018-2030
6.7.3 Israel Cancer Antigen Market Size, 2018-2030
6.7.4 Saudi Arabia Cancer Antigen Market Size, 2018-2030
6.7.5 UAE Cancer Antigen Market Size, 2018-2030
7 Cancer Antigen Companies Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Cancer Antigen Major Product Offerings
7.1.4 Thermo Fisher Scientific Cancer Antigen Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Cancer Antigen Major Product Offerings
7.2.4 Roche Cancer Antigen Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Tellgen
7.3.1 Tellgen Company Summary
7.3.2 Tellgen Business Overview
7.3.3 Tellgen Cancer Antigen Major Product Offerings
7.3.4 Tellgen Cancer Antigen Revenue in Global Market (2018-2023)
7.3.5 Tellgen Key News & Latest Developments
7.4 Labor Diagnostika Nord
7.4.1 Labor Diagnostika Nord Company Summary
7.4.2 Labor Diagnostika Nord Business Overview
7.4.3 Labor Diagnostika Nord Cancer Antigen Major Product Offerings
7.4.4 Labor Diagnostika Nord Cancer Antigen Revenue in Global Market (2018-2023)
7.4.5 Labor Diagnostika Nord Key News & Latest Developments
7.5 Henso Medical (Hangzhou)
7.5.1 Henso Medical (Hangzhou) Company Summary
7.5.2 Henso Medical (Hangzhou) Business Overview
7.5.3 Henso Medical (Hangzhou) Cancer Antigen Major Product Offerings
7.5.4 Henso Medical (Hangzhou) Cancer Antigen Revenue in Global Market (2018-2023)
7.5.5 Henso Medical (Hangzhou) Key News & Latest Developments
7.6 Multisciences (Lianke) Biotech
7.6.1 Multisciences (Lianke) Biotech Company Summary
7.6.2 Multisciences (Lianke) Biotech Business Overview
7.6.3 Multisciences (Lianke) Biotech Cancer Antigen Major Product Offerings
7.6.4 Multisciences (Lianke) Biotech Cancer Antigen Revenue in Global Market (2018-2023)
7.6.5 Multisciences (Lianke) Biotech Key News & Latest Developments
7.7 Hangzhou AllTest Biotech
7.7.1 Hangzhou AllTest Biotech Company Summary
7.7.2 Hangzhou AllTest Biotech Business Overview
7.7.3 Hangzhou AllTest Biotech Cancer Antigen Major Product Offerings
7.7.4 Hangzhou AllTest Biotech Cancer Antigen Revenue in Global Market (2018-2023)
7.7.5 Hangzhou AllTest Biotech Key News & Latest Developments
7.8 SHINJIN Medics
7.8.1 SHINJIN Medics Company Summary
7.8.2 SHINJIN Medics Business Overview
7.8.3 SHINJIN Medics Cancer Antigen Major Product Offerings
7.8.4 SHINJIN Medics Cancer Antigen Revenue in Global Market (2018-2023)
7.8.5 SHINJIN Medics Key News & Latest Developments
7.9 Xiamen Baysen Medica Tech
7.9.1 Xiamen Baysen Medica Tech Company Summary
7.9.2 Xiamen Baysen Medica Tech Business Overview
7.9.3 Xiamen Baysen Medica Tech Cancer Antigen Major Product Offerings
7.9.4 Xiamen Baysen Medica Tech Cancer Antigen Revenue in Global Market (2018-2023)
7.9.5 Xiamen Baysen Medica Tech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Antigen Market Opportunities & Trends in Global Market
Table 2. Cancer Antigen Market Drivers in Global Market
Table 3. Cancer Antigen Market Restraints in Global Market
Table 4. Key Players of Cancer Antigen in Global Market
Table 5. Top Cancer Antigen Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Antigen Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Antigen Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Antigen Product Type
Table 9. List of Global Tier 1 Cancer Antigen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Antigen Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Antigen Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Cancer Antigen Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Antigen Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Cancer Antigen Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Cancer Antigen Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Antigen Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Cancer Antigen Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Cancer Antigen Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Antigen Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Cancer Antigen Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Antigen Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Cancer Antigen Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Antigen Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Cancer Antigen Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Antigen Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Cancer Antigen Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Antigen Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Cancer Antigen Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Antigen Revenue, (US$, Mn), 2024-2030
Table 30. Thermo Fisher Scientific Company Summary
Table 31. Thermo Fisher Scientific Cancer Antigen Product Offerings
Table 32. Thermo Fisher Scientific Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 33. Thermo Fisher Scientific Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Cancer Antigen Product Offerings
Table 36. Roche Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Tellgen Company Summary
Table 39. Tellgen Cancer Antigen Product Offerings
Table 40. Tellgen Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 41. Tellgen Key News & Latest Developments
Table 42. Labor Diagnostika Nord Company Summary
Table 43. Labor Diagnostika Nord Cancer Antigen Product Offerings
Table 44. Labor Diagnostika Nord Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 45. Labor Diagnostika Nord Key News & Latest Developments
Table 46. Henso Medical (Hangzhou) Company Summary
Table 47. Henso Medical (Hangzhou) Cancer Antigen Product Offerings
Table 48. Henso Medical (Hangzhou) Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 49. Henso Medical (Hangzhou) Key News & Latest Developments
Table 50. Multisciences (Lianke) Biotech Company Summary
Table 51. Multisciences (Lianke) Biotech Cancer Antigen Product Offerings
Table 52. Multisciences (Lianke) Biotech Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 53. Multisciences (Lianke) Biotech Key News & Latest Developments
Table 54. Hangzhou AllTest Biotech Company Summary
Table 55. Hangzhou AllTest Biotech Cancer Antigen Product Offerings
Table 56. Hangzhou AllTest Biotech Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 57. Hangzhou AllTest Biotech Key News & Latest Developments
Table 58. SHINJIN Medics Company Summary
Table 59. SHINJIN Medics Cancer Antigen Product Offerings
Table 60. SHINJIN Medics Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 61. SHINJIN Medics Key News & Latest Developments
Table 62. Xiamen Baysen Medica Tech Company Summary
Table 63. Xiamen Baysen Medica Tech Cancer Antigen Product Offerings
Table 64. Xiamen Baysen Medica Tech Cancer Antigen Revenue (US$, Mn) & (2018-2023)
Table 65. Xiamen Baysen Medica Tech Key News & Latest Developments
List of Figures
Figure 1. Cancer Antigen Segment by Type in 2022
Figure 2. Cancer Antigen Segment by Application in 2022
Figure 3. Global Cancer Antigen Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Antigen Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Cancer Antigen Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Antigen Revenue in 2022
Figure 8. By Type - Global Cancer Antigen Revenue Market Share, 2018-2030
Figure 9. By Application - Global Cancer Antigen Revenue Market Share, 2018-2030
Figure 10. By Type - Global Cancer Antigen Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Cancer Antigen Revenue Market Share, 2018-2030
Figure 12. By Application - Global Cancer Antigen Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Cancer Antigen Revenue Market Share, 2018-2030
Figure 14. By Region - Global Cancer Antigen Revenue Market Share, 2018-2030
Figure 15. By Country - North America Cancer Antigen Revenue Market Share, 2018-2030
Figure 16. US Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Cancer Antigen Revenue Market Share, 2018-2030
Figure 20. Germany Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 21. France Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Cancer Antigen Revenue Market Share, 2018-2030
Figure 28. China Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 32. India Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Cancer Antigen Revenue Market Share, 2018-2030
Figure 34. Brazil Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Cancer Antigen Revenue Market Share, 2018-2030
Figure 37. Turkey Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Cancer Antigen Revenue, (US$, Mn), 2018-2030
Figure 41. Thermo Fisher Scientific Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Tellgen Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Labor Diagnostika Nord Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Henso Medical (Hangzhou) Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Multisciences (Lianke) Biotech Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hangzhou AllTest Biotech Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. SHINJIN Medics Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Xiamen Baysen Medica Tech Cancer Antigen Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
